BeOne Medicines Ltd. (ONC)
379.31
+7.33
(+1.97%)
USD |
NASDAQ |
Aug 25, 13:39
BeOne Medicines Total Assets (Quarterly) : 9.176B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.176B |
| March 31, 2026 | 8.554B |
| December 31, 2025 | 8.233B |
| September 30, 2025 | 7.633B |
| June 30, 2025 | 6.299B |
| March 31, 2025 | 5.842B |
| December 31, 2024 | 5.925B |
| September 30, 2024 | 5.831B |
| June 30, 2024 | 5.712B |
| March 31, 2024 | 5.668B |
| December 31, 2023 | 5.805B |
| September 30, 2023 | 5.525B |
| June 30, 2023 | 5.729B |
| March 31, 2023 | 5.957B |
| December 31, 2022 | 6.379B |
| September 30, 2022 | 6.726B |
| June 30, 2022 | 7.378B |
| March 31, 2022 | 8.021B |
| December 31, 2021 | 8.535B |
| September 30, 2021 | 5.286B |
| June 30, 2021 | 5.524B |
| March 31, 2021 | 5.821B |
| Date | Value |
|---|---|
| December 31, 2020 | 5.601B |
| September 30, 2020 | 5.566B |
| June 30, 2020 | 3.903B |
| March 31, 2020 | 4.067B |
| December 31, 2019 | 1.612B |
| September 30, 2019 | 1.881B |
| June 30, 2019 | 2.150B |
| March 31, 2019 | 2.172B |
| December 31, 2018 | 2.250B |
| September 30, 2018 | 2.409B |
| June 30, 2018 | 1.654B |
| March 31, 2018 | 1.709B |
| December 31, 2017 | 1.047B |
| September 30, 2017 | 1.049B |
| June 30, 2017 | 473.98M |
| March 31, 2017 | 376.73M |
| December 31, 2016 | 405.81M |
| September 30, 2016 | 235.42M |
| June 30, 2016 | 251.23M |
| March 31, 2016 | 265.23M |
| December 31, 2015 | 116.76M |
| September 30, 2015 | 135.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 2.651B |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 186.45M |
| Idorsia Ltd. | 575.13M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.973B |
| Shareholders Equity (Quarterly) | 5.174B |
| Debt to Equity Ratio | 0.3961 |
| Current Ratio | 3.405 |
| Net Debt Paydown Yield | -0.71% |